pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 371 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 2
    CA-002
    Peanut Allergy Cambridge Allergy Ltd
  • Preclinical
    CAMKK2 Inhibitors
    Transplant Rejection Eyedesis Biosciences LLC
  • Phase 1
    CAN-10
    Hidradenitis Suppurativa Otsuka Pharmaceutical Co Ltd
  • Preclinical
← prev
page 4 of 13
next →
Pain89
Neurology1
CD6/CTLA4 CAR-Treg-Dermatological Basket
Psoriasis
Immuthera Inc
  • Preclinical
    CEL-4000
    Rheumatoid Arthritis CEL-SCI Corp
  • Preclinical
    CHT-103
    Hematological Tumor Nanjing Miracle Biotechnology Co Ltd
  • Preclinical
    CHT-104
    Hematological Tumor Nanjing Miracle Biotechnology Co Ltd
  • Preclinical
    CHT-105
    Autoimmune Disorders Nanjing Miracle Biotechnology Co Ltd
  • Phase 1
    CLN-978
    Systemic Lupus Erythematosus$CGEM Cullinan Therapeutics, Inc.
  • Phase 2
    CNP-106
    Myasthenia Gravis Cour Pharmaceuticals Development Co Inc
  • Phase 2
    CTO-1681
    Cytokine Release Syndrome (Cytokine Storm) CytoAgents Inc
  • Preclinical
    CTP-45
    Autoimmune Disorders Celltrion Inc
  • Preclinical
    CTP-68
    Autoimmune Disorders Celltrion Inc
  • Phase 2
    CYP-001
    Graft Versus Host Disease (GVHD) Cynata Therapeutics Ltd
  • Marketed
    Cutaquig
    Cutaquig (immune globulin (human))
    Primary Immune Deficiency (PID)$PFE PFIZER INC
  • Marketed
    D-Penamine
    Depen (penicillamine)
    Rheumatoid Arthritis Mylan Specialty LP
  • Phase 2
    DBV-135
    Milk Allergy DBV Technologies SA
  • Phase 2
    DS-7011
    Cutaneous Lupus Erythematosus Daiichi Sankyo Co Ltd
  • Phase 2
    DSG3-CAART
    Pemphigus Vulgaris$CABA Cabaletta Bio, Inc.
  • Phase 3
    Descartes-08
    Myasthenia Gravis$RNAC Cartesian Therapeutics, Inc.
  • Marketed
    Desowen
    Desonide Actavis (desonide)
    Psoriasis Teva Pharmaceuticals USA Inc
  • Phase 2
    EG-501
    Cognitive Impairment Shenzhen Evergreen Therapeutics Co Ltd
  • Preclinical
    EYD-001
    Systemic Sclerosis (Scleroderma) Eydis Bio Inc
  • Marketed
    Enstilar
    Betamethasone Dipropionate + Calcipotriene Perrigo ((betamethasone dipropionate + calcipotriene))
    Plaque Psoriasis (Psoriasis Vulgaris) Perrigo New York Inc
  • Phase 2
    F-652
    Alcoholic Hepatitis Evive Biotech
  • Phase 1
    FMT-XBI-302
    Graft Versus Host Disease (GVHD) Shenzhen UnknownBio Biotechnology Co Ltd
  • Phase 1
    FT-819
    Idiopathic Inflammatory Myopathy (IIM)$FATE FATE THERAPEUTICS INC
  • Preclinical
    FT-839
    Hematological Tumor$FATE FATE THERAPEUTICS INC
  • Preclinical
    FT-8XX
    Unspecified Cancer$FATE FATE THERAPEUTICS INC
  • Preclinical
    Fusion Protein to Antagonize IL1R for Schnitzler Syndrome
    Schnitzler Syndrome R-Pharm